Altogether, our results provide mechanistic insight to the development of kidney transplant rejection in subjects receiving non-lymphodepletional induction therapy and suggest monitoring of circulating CD8+ DRTC over time may be a surrogate for ongoing allograft inflammation. The gene discussed is CD8A; the disease is medical procedure.